-
Santhera, Rutgers Partner on LAMA2 Muscular Dystrophy Gene Therapy
Santhera has announced agreements with Rutgers University to develop potential gene therapies for congenital MD type 1A focused on the use of linker proteins. Read more here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.